Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | BMC Cancer

Fig. 3

From: EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus

Fig. 3

Kaplan-Meier survival curves of intestinal-type oesophagogastric cancer patients with or without EGFR or HER2 amplification. Time to recurrence (ab) and cancer-specific survival (cd) as based on EGFR (a, c) and HER2 (b, d) SISH and IHC analyses. IHC, immunohistochemistry; SISH, silver in situ hybridisation

Back to article page